Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	35.18	23.86	17.65
Graham Fair Price	-70.00	4.26	14.20
PEG	160.04	-0.80	0.31
Price/Book	5.52	2.55	2.42
Price/Cash Flow	0.52	120.60	119.98
Prices/Earnings	953.25	87.24	-8.28
Price/Sales	0.74	1.55	1.54
Price/FCF	0.52	120.60	119.98
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	-1.78	0.51	0.52
Operating Margin	-30.91	0.06	0.09
ROA	-90.58	< 0.005	-0.02
ROE	-0.07	< 0.005	-89.98
ROIC	-0.07	< 0.005	-87.69
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	-0.02	-88.09
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	3.39	-0.31	-90.89
EPS QOQ	0.27	1.09	305.04
FCF QOQ	-0.88	< 0.005	-99.76
Revenue QOQ	-0.04	< 0.005	99.82
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	9.08	9.63	6.06
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.32	0.33	3.30
Quick Ratio	0.46	0.49	5.68
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	11.08	10.51	-5.23
Cash	1.54	1.86	20.91
Capex	0.00	0.00	0.00
Free Cash Flow	0.22	0.22	-0.52
Revenue	17.35	17.22	-0.74
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.46	0.49	5.68
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.17	2.69	24.02
Naive Interpretation	Member

06 - Financial Health · Bad

Rating